EDGAR Filing Documents for 0001400482-17-000057

Form 8-K - Current report:

SEC Accession No. 0001400482-17-000057

Filing Date

2017-05-25

Accepted

2017-05-25 17:14:43

Documents

Period of Report

2017-05-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	kph20170524_8-kxseattlelea.htm	8-K	31728
2	EXHIBIT 10.1	exhibit101-integrateddiagn.htm	EX-10.1	655541
3		a818stewart1.jpg	GRAPHIC	47157
4		a818stewart2.jpg	GRAPHIC	50995
5		a818stewart3.jpg	GRAPHIC	3087
6		blnotary.jpg	GRAPHIC	13384
7		exhibita.jpg	GRAPHIC	88326
8		exhibitc1.jpg	GRAPHIC	73656
9		exhibitc2.jpg	GRAPHIC	21843
10		ksnotarya01.jpg	GRAPHIC	14521
11		lanotary.jpg	GRAPHIC	7335
12		pmnotary.jpg	GRAPHIC	13619
13		scnotary.jpg	GRAPHIC	13534
14		swnotary.jpg	GRAPHIC	14653
	Complete submission text file	0001400482-17-000057.txt		1161749

Mailing Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013

Business Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013 81 3 5789-5872

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 981295657 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55133 | Film No.: 17870940
SIC: 2834 Pharmaceutical Preparations